PubMed

The AngelMed Guardian system: Is there a role for implantable devices for early detection of coronary artery occlusion?

PMID: 27847262 · 2016-10-08

T, o, b, y, , R, o, g, e, r, s, ;, , A, r, i, e, , S, t, e, i, n, v, i, l, ;, , R, e, b, e, c, c, a, , T, o, r, g, u, s, o, n, ;, , R, o, n, , W, a, k, s, m, a, n

ЖурналCardiovascular revascularization medicine : including molecular interventions

Год2016-10-08

PMID27847262

Аннотация

The AngelMed Guardian System is an implantable device similar to a single chamber pacemaker that continuously monitors the intracardiac electrogram for evidence of ST segment shift indicating acute coronary artery occlusion. The system aims to reduce time to presentation by alerting patients to present to a medical facility whether symptoms are present or not. In March 2016, the US Food and Drug Administration (FDA) assembled a meeting of the Circulatory System Devices Panel to review the result

Официальный источник

Открыть в PubMed →

Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.